NM_003238.6:c.-622_-621delAC

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2

The NM_003238.6(TGFB2):​c.-622_-621delAC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00768 in 145,156 control chromosomes in the GnomAD database, including 5 homozygotes. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0077 ( 5 hom., cov: 28)

Consequence

TGFB2
NM_003238.6 5_prime_UTR

Scores

Not classified

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.336

Publications

1 publications found
Variant links:
Genes affected
TGFB2 (HGNC:11768): (transforming growth factor beta 2) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]
TGFB2-AS1 (HGNC:50628): (TGFB2 antisense RNA 1 (head to head))

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP6
Variant 1-218346056-GCA-G is Benign according to our data. Variant chr1-218346056-GCA-G is described in ClinVar as Likely_benign. ClinVar VariationId is 295476.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00768 (1115/145156) while in subpopulation SAS AF = 0.013 (57/4386). AF 95% confidence interval is 0.0103. There are 5 homozygotes in GnomAd4. There are 572 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check.
BS2
High AC in GnomAd4 at 1115 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003238.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
NM_003238.6
MANE Select
c.-622_-621delAC
5_prime_UTR
Exon 1 of 7NP_003229.1P61812-1
TGFB2
NM_001135599.4
c.-622_-621delAC
5_prime_UTR
Exon 1 of 8NP_001129071.1P61812-2
TGFB2
NR_138148.2
n.745_746delAC
non_coding_transcript_exon
Exon 1 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TGFB2
ENST00000366930.9
TSL:1 MANE Select
c.-622_-621delAC
5_prime_UTR
Exon 1 of 7ENSP00000355897.4P61812-1
TGFB2-AS1
ENST00000774588.1
n.239-670_239-669delTG
intron
N/A
TGFB2-AS1
ENST00000774589.1
n.32-670_32-669delTG
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00765
AC:
1110
AN:
145080
Hom.:
5
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.00483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0106
Gnomad ASJ
AF:
0.0177
Gnomad EAS
AF:
0.00485
Gnomad SAS
AF:
0.0135
Gnomad FIN
AF:
0.00939
Gnomad MID
AF:
0.00649
Gnomad NFE
AF:
0.00768
Gnomad OTH
AF:
0.0132
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00768
AC:
1115
AN:
145156
Hom.:
5
Cov.:
28
AF XY:
0.00809
AC XY:
572
AN XY:
70666
show subpopulations
African (AFR)
AF:
0.00494
AC:
196
AN:
39654
American (AMR)
AF:
0.0107
AC:
157
AN:
14668
Ashkenazi Jewish (ASJ)
AF:
0.0177
AC:
60
AN:
3392
East Asian (EAS)
AF:
0.00487
AC:
23
AN:
4718
South Asian (SAS)
AF:
0.0130
AC:
57
AN:
4386
European-Finnish (FIN)
AF:
0.00939
AC:
89
AN:
9480
Middle Eastern (MID)
AF:
0.00709
AC:
2
AN:
282
European-Non Finnish (NFE)
AF:
0.00769
AC:
505
AN:
65710
Other (OTH)
AF:
0.0131
AC:
26
AN:
1990
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
53
107
160
214
267
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00175
Hom.:
1

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Loeys-Dietz syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.34

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151329324; hg19: chr1-218519398; COSMIC: COSV65108342; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.